| dc.description.abstract | Background: Cardiovascular diseases represented the most significant
portion of catastrophic healthcare expenditure, comprising 49% of total
Social Security Agency on Health claims. Of the total Rp 20 trillion in
catastrophic costs, approximately Rp 9.8 trillion was allocated by Social
Security Agency on Health for the provision of healthcare services to JKN-
KIS enrollees diagnosed with heart diseases, encompassing 12.9 million
cases.
Objective: The objective of this study is to determine the single and
combination antihypertensive regimens, as well as the cost-effectiveness of
these treatments, among hospitalized patients with congestive heart failure
at H. Adam Malik General Hospital, Medan.
Methods: This study is a non-experimental research aimed at analyzing the
cost-effectiveness of outpatient congestive heart failure treatment at H.
Adam Malik Hospital, Medan, from the hospital's perspective, based on the
CER and ICER values.
Result: The results showed that Congestive Heart Failure (CHD) patients
had single and combined hypertension therapy models with the following
percentages CCB + ACEI + Diuretics (25%), BB + Diuretics +ARB (13%),
CCB +ACEI + Diuretics +ARB (11%), CCB + Diuretics (11%), Diuretics
(9%), CCB +BB +ARB (9%), ACEI +BB + Diuretics (9%), CCB +
Diuretics +ARB (6%), CCB +BB + Diuretics +ARB (6%). According to
CER and ICER calculations, the most cost-effective antihypertensive
therapy model is CCB + Diuretics therapy with a CER of Rp. 2,706.03 with
an ICER of -Rp. 9,789.48.
Conclusion: The results showed on CER and ICER calculations, the most
cost-effective antihypertensive therapy model is CCB + Diuretics. | en_US |
